Japan Drug Forecasts to 2024

Text with Title

Evaluate Japan Drug Forecasts gives you the understanding and time you need to drive better decisions.

Conduct external benchmarking and market analysis with the first consensus forecasts for Japan. Our industry-leading consensus forecasts, combined with historical sales and sales by indication for the Japanese market, will help you make business critical decisions faster.

Evaluate Japan Drug Forecasts cover over 1,000 marketed and R&D products, which made up over 80% of the total Japanese market value in 2016.

Contact Us Download Brochure

Product valuation and competitive analysis

Create product and company portfolio valuations for the Japan market with standardised consensus forecasts to 2024.

Model the future dynamics of the Japanese market to 2024 and compare to worldwide, USA and EU consensus forecasts.

Contact Us
Fragmented World
Data coverage of the past, present and future

Market sizing and horizon scanning

Benchmark product performance and map uptake trends and key drivers for the Japan market.

Model product sales at indication level and identify the key growth drivers. Map pipeline assets likely to launch by 2024 and measure the impact to understand future asset values.

Download Brochure
 

Request more information

Evaluate is not a package I can do without... It's an absolute timesaver and if you're saving time, you're saving money.

ANTHONY M, SENIOR DIRECTOR, COMPETITIVE INTELLIGENCE & PROSPECTION, NOVARTIS

Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry.

DR. HIROHISA NAKADA, ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, OTSUKA HOLDINGS